MetaCap

Ginkgo Bioworks (DNA) vs Electra Therapeutics (ETRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Electra Therapeutics is the larger company by market cap ($509.8 million vs $483.5 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DNA-5.33%ETRA-38.79%
+97%+23%-52%
Sep 18, 20261 yearNov 20, 2026
DNA-5.33%ETRA-38.79%
+70%+12%-46%
Sep 14, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DNA versus ETRA key metrics
MetricDNAETRA
Share price$7.46$8.11
Market cap$483.54M$509.85M
1-day change-9.02%-9.28%
YTD return-10.23%—
1-year return-8.69%—
5-year return-98.45%—
EPS (TTM)$-4.24$-35.94
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$170.16M—
Revenue growth (YoY)-25.06%—
Net income (latest FY)$-312.76M—
Operating margin-185.29%—
Net margin-183.81%—
52-week high$18.22$15.50
52-week low$5.37$6.87
Distance from 52-week high-59.06%-47.68%
Analyst consensusunderperformstrong_buy
Avg. price target upside+7.24%+309.37%
Average volume2.53M559.28K
Shares outstanding53.94M62.87M
Employees48546
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Ginkgo Bioworks

DNA stock →

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 485 employees

About Electra Therapeutics

ETRA stock →

Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees

DNA vs ETRA FAQ

Which is bigger, Ginkgo Bioworks or Electra Therapeutics?

Electra Therapeutics (ETRA) is larger, with a market capitalization of $509.85M compared with $483.54M for Ginkgo Bioworks (DNA).

Are Ginkgo Bioworks and Electra Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons